NCT03420963 2026-03-03
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Terminated
Clinical Trials
23 trialsNCT02870907 2026-01-07
RB SFCE 09
Institut Curie
Phase 2 Active not recruiting
NCT04681417 2025-11-28
RETINO 2018
Institut Curie
Phase 2/3 Recruiting
NCT00186888 2025-09-04
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
St. Jude Children's Research Hospital
Phase 3 Completed
NCT01783535 2024-04-16
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT01505569 2024-02-26
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Masonic Cancer Center, University of Minnesota
Phase NA Completed
NCT05080010 2021-10-15
Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
Sun Yat-sen University
Phase 3 Recruiting
NCT00179920 2020-08-05
Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 2 Completed
NCT02116959 2020-04-16
Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma
University of California, San Francisco
Phase 1 Terminated
NCT02638428 2020-03-19
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Samsung Medical Center
Phase 2 Unknown
NCT03628131 2018-09-19
Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors
Samsung Medical Center
Phase 1/2 Unknown
NCT02194049 2018-01-09
Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer
University of California, Davis
Phase 1 Completed
NCT00623077 2017-12-05
MT2004-30: Tomotherapy for Solid Tumors
Masonic Cancer Center, University of Minnesota
Phase 1 Terminated
NCT00003273 2015-12-03
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
NYU Langone Health
Phase 2 Withdrawn
NCT02319486 2015-03-30
CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma
Sun Yat-sen University
Phase 4 Completed
NCT02137928 2014-12-19
Carboplatin Periocular Injection for Retinoblastoma
Sun Yat-sen University
Phase 3 Unknown
NCT01899066 2014-05-13
Efficacy Study of Lucentis in the Treatment of Retinoblastoma
Sun Yat-sen University
Phase 2 Unknown
NCT00009815 2013-12-19
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
University of Pittsburgh
Phase 1 Withdrawn
NCT00002675 2013-06-28
Chemotherapy in Treating Patients With Retinoblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00551005 2012-11-22
Etoposide and Celecoxib in Patients With Advanced Cancer
City of Hope Medical Center
Phase 1 Completed
NCT00006047 2012-09-26
Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00573690 2012-04-24
Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT00004006 2011-10-04
Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
St. Jude Children's Research Hospital
Phase 2 Completed